Introduction
Meningitis caused by Cryptococcus neoformans is rare in Britain and is known for its frequent association with debilitating disease and for the difficulties involved in its diagnosis and treatment. The two cases described showed no evidence of predisposing disease.
Case 1
A 64-year-old Newcastle housewife had for six months been feeling " shaky," especially when walking, and had tended to deviate to the left. Recently she had been excessively sleepy, increasingly deaf, and mildly dysarthric, and just before her admission she became depressed and confused. She had lost 12-7 kg. in weight. She denied headache, but had vomited repeatedly in the mornings. She was admitted to the department of psychological medicine, where examination of the cerebrospinal fluid (CS.F.) showed evidence of a chronic meningitis ; repeated searches for acid-fast bacilli and fungi, however, were negative.
She was transferred to the neurological unit with a provisional diagnosis of sarcoid meningitis. On examination she was thin and ill but apyrexial; the chest, abdomen, and pelvis were normal. She was confused and disorientated in time and place, had bilateral anosmia and mild perceptive deafness but no other cranial nerve abnormalities, and the fundi were normal. Neck stiffness was absent. There was a fine tremor of the outstretched hands with brisk reflexes in all four limbs, absent abdominal reflexes, and bilateral extensor plantar responses. She remained depressed in spite of antidepressant therapy.
Investigations.-Blood count and E.S.R., blood urea, and serum proteins were all normal; serum calcium was 8-7 mg./100 ml., Wassermann reaction and Reiter protein complement fixation test were negative in blood and C.S.F. Repeated C.S.F. examinations showed white cell counts of 75-177/cu. mm., predominantly pnlymorphs, sugar 15-18 mg./100 ml., and protein Nine months after the completion of treatment she was still rather ataxic, but she felt well and was able to do her housework.
Immunological tests for C. neoformans remained negative in serum and C.S.F.
Case 2 A 24-year-old male student from New Guinea, who had also travelled in Australia, had been in this country for one year. His previous health had been good, but two weeks before admission he had developed severe frontal headache, fever, and anorexia, which.
were followed after a week by pain in his neck and back, diplopia on lateral gaze, and unsteadiness when walking.
On admission to hospital he had a temperature of 37 2' C. and, signs of meningism. The visual acuity, visual fields, and fundi were normal. He had fine phasic nystagmus on lateral gaze and mild bilateral sixth nerve pareses but no other cranial nerve abnormality. There was no limb weakness, but all tendon reflexes were diminished and there was a mild truncal ataxia, Further examination was negative.
Investigations.-E.S.R. 64 mm./hour (Westergren). A blood count and radiographs of skull and chest were normal. The C.S.F. was under high pressure and contained 125 white cells/cu. mm., mostly lymphocytes, protein 26 mg./100 ml., and sugar 54 mg./ 100 ml. Encapsulated yeasts were seen on direct microscopy and C. neoformans was later isolated on culture. Two days later the C.S.F. sugar fell to 40 mg./100 ml. Agglutination tests for cryptococcal antigen and antibody were positive in serum and in C.S.F. in high titres.
An infusion of amphotericin B was started and within four hours he became restless and confused, began to vomit, and had severe rigors with a rise of temperature to 40' C. These symptoms recurred each day when the infusion was started but were minimized by large doses of promethazine.
A week after treatment was started he developed a mild right hemiparesis, right lower motor neurone facial paresis, slurring dysarthria, and coarse nystagmus in the adducting eye on looking to the left. Cryptococci were still being cultured from the C.S.F. It was thought that he had developed a basal meningitis and he was given intravenous hydrocortisone 50 mg. three times daily and intrathecal amphotericin B 0 05 mg. daily, gradually increased to 0 75 mg. daily, and then maintained at this level for 10 days despite severe headaches, backache, and incontinence of urine following its administration. Shortly after this all treatment with amphotericin B had to be stopped, as his blood urea rose to 90 mg./100 ml. and remained so despite a reduction in the intravenous dose. He had received a total of only 350 mg. of the drug. Prednisone 30 mg. daily was continued and his symptoms improved. Though this was no doubt in part due to discontinuing the amphotericin B. there was also by this time improvement in the serum cryptococcal agglutination titres. The C.S.F., however, was still abnormal (Fig. 1) At this time a supply of 5-fluorocytosine became available. He was treated with this drug in the recommended dose of 100 mg./kg. body weight/day and from then on symptomatic improvement was very rapid. After five days he was fully lucid and was able to sit out of bed for the first time. After a week's treatment there were only 10 lymphocytes per cu. mm. in the C.S.F., the protein was 21 mg./100 ml. and sugar 61 mg./100 ml. He had no symptomatic side-effects from this drug, but there was a transient rise in the serum aspartate aminotransferase. After four weeks of treatment he was fully alert and had no symptoms or neurological signs except persistent central scotomata. 5-Fluorocytosine (6 g./day) was given for 43 days. Just before the end of the course the C.S.F. lymphocyte count increased, and three days after the drug was withdrawn there was a recurrence of headache and backache with a further deterioration in the C.S.F. findings (Fig. 1) . 5-Fluorocytosine was given again in a dose of 9 g. and then 12 g. daily for a further 'Fetter et al., 1967 The introduction of treatment with amphotericiLn B reduced the mortality of cryptococcal meningitis from about 90'> in the first year to 25 % over three years (Williams, 1967) . The drug must, however, be given intravenously in a dose which can rarely exceed 1 mg./kg. body weight/day, until a total of 3 g. has been given. In addition, during the active stages of the disease intrathecal administration (0-025 mg. increasing to 0 5 mg. daily) is recommended. Even in these low dosages amphotericin B may have severe side-effects, the most important of which, apart from idiosyncratic reactions, is impaired renal function. This occurs in 80% of treated cases, though permanent renal damage can usually be prevented by reducing the dose (Williams, 1967) . In Case 1 a full and succesful course of 5 July 1969
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MEDICAL JONA 31 necessitated withdrawal of the drug after only 350 mg. had been given. The blood urea returned to normal in a few days but the patient then developed an acute meningitis which was probably simply an exacerbation of the torulosis. Fortunately at this time a supply of 5-fluorocytosine became available. 5-Fluorocytosine (Fig. 2) is not yet generally available in this country but has been tried in the treatment of cryptococcal meningitis in the U.S.A. (Grunberg et al., 1967) . It is reported to be an antimetabolite of cytosine in C. neoformans, Candida albicans, and other fungi, but apparently not in man. It is effective in inhibiting the growth of these fungi but has apparently no antibacterial effect.
In man, after single oral doses of 2 g. of 5-fluorocytosine fungistatic concentrations persist in the blood for 6 to 10 hours. It is excreted unchanged in the urine. A single case of reversible pancytopenia after four weeks of treatment with 5-fluorocytosine was reported at secondhand by Tassel and Madoff (1968) , and a transient rise in serum transaminases has occurred in one previous patient. In one patient with cryptococcal meningitis who failed to respond to amphotericin B (3 4 g. intravenously over a period of three months) the symptoms improved and the C.S.F. became free from cryptococci after six weeks of treatment with 5-fluorocytosine. The C.S.F. concentration of the drug was almost equal to the blood level (I. Lenox-Smith, personal communication, 1968) . Tassel and Madoff (1968) described a case resistant to amphotericin B. in which the patient responded to treatment with 5-fluorocytosine in a dose of 2 25 g. daily for 50 days. In addition a number of patients with systemic candidiasis have apparently been successfully treated. The response to treatment in our own patient has been satisfactory, though it is too early to be certain of the prognosis in this disorder, in which the relapse rate is notoriously high. Because of the advantage of oral administration and its relative freedom from side-effects it may be, however, that 5-fluorocytosine will replace amphotericin B as the first choice in the treatment of cryptococcosis; certainly it merits further trials.
Bronchial lavage as a treatment for severe status asthmaticus in adults was described by Broom (1960) . More recently Ambiavagar and Jones (1967) described a regimen of management combining this with intermittent positive-pressure ventilation (I.P.P.V.). We report here the successful resuscitation of a moribund child by this technique, following mainly the recommendations of the latter two authors.
CASE REPORT
The patient, a boy aged 14, had a history of asthma for five years and had been admitted to hospital for status asthmaticus eight months previously. He had then responded to a short course of steroids and had not since required any treatment. He was readmitted in status asthmaticus with a two-day history of respiratory infection and wheezing treated with choline theophyllinate (Choledyl) 
